Growth Metrics

Alkermes (ALKS) Common Equity (2016 - 2026)

Alkermes has reported Common Equity over the past 16 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly Common Equity rose 24.19% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, up 24.19% year-over-year, with the annual reading at $1.8 billion for FY2025, 24.19% up from the prior year.
  • Common Equity was $1.8 billion for Q4 2025 at Alkermes, up from $1.7 billion in the prior quarter.
  • Over five years, Common Equity peaked at $1.8 billion in Q4 2025 and troughed at $1.0 billion in Q1 2023.
  • The 5-year median for Common Equity is $1.2 billion (2023), against an average of $1.3 billion.
  • Year-over-year, Common Equity dropped 6.49% in 2023 and then soared 34.16% in 2025.
  • A 5-year view of Common Equity shows it stood at $1.1 billion in 2021, then decreased by 6.19% to $1.0 billion in 2022, then increased by 15.23% to $1.2 billion in 2023, then grew by 21.81% to $1.5 billion in 2024, then grew by 24.19% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Common Equity are $1.8 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.6 billion (Q2 2025).